Literature DB >> 6221751

Decreased T helper cells in the myelodysplastic syndromes.

A G Bynoe, C S Scott, P Ford, B E Roberts.   

Abstract

The myelodysplastic syndromes (MDS) are disorders in which the abnormalities are thought to be confined to cells of the myeloid series. However, examination of peripheral blood from 56 patients with MDS showed that the majority had low lymphocyte counts. In a detailed study of 25 patients, using OKT3, OKT4 and OKT8 monoclonal antisera together with SRBC rosettes, it was shown that there is a consistent and significant reduction in peripheral blood T lymphocytes. This decrease was primarily confined to the OKT4-defined helper subpopulation. There is a consequent relative increase in the OKT8-defined subset but in absolute numbers however, suppressor cells are reduced compared to normal particularly in those patients with lymphopenia. No correlations between T cell abnormalities and the different morphological groups of MDS were found. The possible implications of the reversed helper/suppressor ratio in the pathogenesis of MDS are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6221751     DOI: 10.1111/j.1365-2141.1983.tb02071.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  14 in total

1.  Coincidence of primary myelodysplastic syndrome and non-Hodgkin lymphoma.

Authors:  R Schulze; G Schlimok; D Renner
Journal:  Clin Investig       Date:  1992-12

2.  Interferon-gamma and tumor necrosis factor-alpha induce an immunoinhibitory molecule, B7-H1, via nuclear factor-kappaB activation in blasts in myelodysplastic syndromes.

Authors:  Asaka Kondo; Taishi Yamashita; Hideto Tamura; Wanhong Zhao; Takashi Tsuji; Masumi Shimizu; Eiji Shinya; Hidemi Takahashi; Koji Tamada; Lieping Chen; Kazuo Dan; Kiyoyuki Ogata
Journal:  Blood       Date:  2010-05-14       Impact factor: 22.113

3.  Erythrocyte autoantibodies, autoimmune haemolysis, and myelodysplastic syndromes.

Authors:  R J Sokol; S Hewitt; D J Booker
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

4.  CD4 deficiency in myelodysplastic syndrome with monosomy 7.

Authors:  C M Weemaes; F Preijers; G A de Vaan; J A Bakkeren; I S Klasen; A Haraldsson
Journal:  Eur J Pediatr       Date:  1996-02       Impact factor: 3.183

Review 5.  The myelodysplastic syndromes.

Authors:  D M Layton; G J Mufti
Journal:  Br Med J (Clin Res Ed)       Date:  1987-07-25

Review 6.  Myelodysplastic syndromes.

Authors:  D C Doll; A F List
Journal:  West J Med       Date:  1989-08

7.  Myelodysplastic syndrome associated with relapsing polychondritis: unusual transformation from refractory anemia to chronic myelomonocytic leukemia.

Authors:  T Shirota; O Hayashi; H Uchida; N Tonozuka; N Sakai; H Itoh
Journal:  Ann Hematol       Date:  1993-07       Impact factor: 3.673

8.  Analysis of bone marrow and peripheral blood immunoregulatory lymphocytes in patients with myelodysplastic syndrome.

Authors:  O Iwase; S Aizawa; Y Kuriyama; M Yaguchi; M Nakano; K Toyama
Journal:  Ann Hematol       Date:  1995-12       Impact factor: 3.673

Review 9.  Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications.

Authors:  A Jacobs
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

10.  Bone marrow lymphocyte subsets in myelodysplastic syndromes.

Authors:  W Hilbe; W Eisterer; C Schmid; I Starz; H Silly; C Duba; C Ludescher; J Thaler
Journal:  J Clin Pathol       Date:  1994-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.